Works matching IS 10685308 AND DT 2002 AND VI 13 AND IP 5
Results: 10
'Not approvable' letter for transdermal selegiline.
- Published in:
- Brown University Psychopharmacology Update, 2002, v. 13, n. 5, p. 8
- Publication type:
- Article
FDA issues a warning for kava.
- Published in:
- Brown University Psychopharmacology Update, 2002, v. 13, n. 5, p. 8
- Publication type:
- Article
'Dear Doctor' letter and labeling change for ziprasidone.
- Published in:
- Brown University Psychopharmacology Update, 2002, v. 13, n. 5, p. 8
- Publication type:
- Article
Transdermal patch for ADHD successful in Phase III trials.
- Published in:
- Brown University Psychopharmacology Update, 2002, v. 13, n. 5, p. 8
- Publication type:
- Article
Donepezil studied for cognitive impairment of schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2002, v. 13, n. 5, p. 7
- Publication type:
- Article
St. John's wort vs. sertraline study causes controversy.
- Published in:
- Brown University Psychopharmacology Update, 2002, v. 13, n. 5, p. 5
- Publication type:
- Article
Phenelzine (generic)˜Nardil (brand).
- Published in:
- Brown University Psychopharmacology Update, 2002, v. 13, n. 5, p. 5
- Publication type:
- Article
Serotonin syndrome possibly caused by SSRIs and metoclopramide.
- Published in:
- Brown University Psychopharmacology Update, 2002, v. 13, n. 5, p. 2
- By:
- Publication type:
- Article
Typical depression patients excluded from drug trials.
- Published in:
- Brown University Psychopharmacology Update, 2002, v. 13, n. 5, p. 1
- Publication type:
- Article
Will genetics revolutionize way drugs are prescribed?
- Published in:
- Brown University Psychopharmacology Update, 2002, v. 13, n. 5, p. 1
- Publication type:
- Article